Pandemic Flu Case Analysis
Just-In-Time vs. Just-In-Case Strategy: What is the optimal Influenza vaccine production quantities to prevent a public health catastrophe, prevent vaccine major vaccine shortages and surpluses all the while maximizing profitability? Optimization Case Analysis.
Background
Mitchell, a manager at the leading flu vaccine manufacturer, CSP Inc., needs to determine the optimal production plan for the upcoming flu season while balancing the interests of the company with the need to promote public health. The flu vaccine industry is characterized by unpredictable demand, with production lead time of 6-8 months and distribution through direct sales or distributors. Michael is torn between the "just-in-time" and "just-in-case" production strategies and needs to consider the role of the government in the value chain. The objective is to suggest a production plan that benefits both the company and public health while estimating all possible demand scenarios.
